Published in J Child Neurol on December 12, 2008
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther (2011) 2.06
Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up. J Neurol (2011) 1.28
Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): case definition in surveillance for childhood-onset Duchenne/Becker muscular dystrophy. J Child Neurol (2010) 1.12
A novel splicing silencer generated by DMD exon 45 deletion junction could explain upstream exon 44 skipping that modifies dystrophinopathy. J Hum Genet (2014) 0.88
Assessment of the structural and functional impact of in-frame mutations of the DMD gene, using the tools included in the eDystrophin online database. Orphanet J Rare Dis (2012) 0.82
A comprehensive database of Duchenne and Becker muscular dystrophy patients (0-18 years old) in East China. Orphanet J Rare Dis (2015) 0.81
Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45. Ann Neurol (2015) 0.80
Prevalence and Characteristics of Chinese Patients With Duchenne and Becker Muscular Dystrophy: A Territory Wide Collaborative Study in Hong Kong. Child Neurol Open (2015) 0.75
Distribution of dystrophin gene deletions in a Chinese population. J Int Med Res (2016) 0.75
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol (2009) 8.42
Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci (2004) 6.99
Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature (2002) 5.21
Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med (2008) 4.65
The epidemiology of autism spectrum disorders. Annu Rev Public Health (2007) 4.52
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol (2009) 4.27
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A (2009) 4.18
Antisense oligonucleotide therapy for neurodegenerative disease. J Clin Invest (2006) 3.00
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol (2008) 2.95
Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron (2004) 2.94
Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). J Pediatr (2009) 2.90
Newborn screening for Krabbe disease: the New York State model. Pediatr Neurol (2009) 2.88
Cell-phone-based platform for biomedical device development and education applications. PLoS One (2011) 2.84
A public health collaboration for the surveillance of autism spectrum disorders. Paediatr Perinat Epidemiol (2007) 2.36
Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc Natl Acad Sci U S A (2008) 2.35
Effectiveness of pulse oximetry screening for congenital heart disease in asymptomatic newborns. Pediatrics (2003) 2.35
Maternal occupational exposure to organic solvents during early pregnancy and risks of neural tube defects and orofacial clefts. Occup Environ Med (2012) 2.35
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci U S A (2013) 2.31
Increased prevalence of renal and urinary tract anomalies in children with congenital hypothyroidism. J Pediatr (2008) 2.20
In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation. J Clin Invest (2007) 2.18
A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9. Nat Genet (2012) 2.12
Intrapartum management of category II fetal heart rate tracings: towards standardization of care. Am J Obstet Gynecol (2013) 2.10
Maternal obesity and congenital heart defects: a population-based study. Am J Clin Nutr (2010) 2.06
Why primate models matter. Am J Primatol (2014) 2.05
Alcohol consumption by women before and during pregnancy. Matern Child Health J (2008) 1.94
Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology (2002) 1.94
Socioeconomic inequality in the prevalence of autism spectrum disorder: evidence from a U.S. cross-sectional study. PLoS One (2010) 1.93
ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nat Genet (2012) 1.93
Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. Hum Mutat (2009) 1.88
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc Natl Acad Sci U S A (2013) 1.88
Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology (2007) 1.67
LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy. Ann Neurol (2013) 1.63
Maternal asthma medication use and the risk of gastroschisis. Am J Epidemiol (2008) 1.62
Limb-girdle muscular dystrophy in the United States. J Neuropathol Exp Neurol (2006) 1.59
Mutations in PHF6 are associated with Börjeson-Forssman-Lehmann syndrome. Nat Genet (2002) 1.57
Residential mobility during pregnancy and the potential for ambient air pollution exposure misclassification. Environ Res (2009) 1.56
Clinical and genetic features of hearing loss in facioscapulohumeral muscular dystrophy. Neurology (2013) 1.53
Treatment of refractory status epilepticus with hemispherectomy. Epilepsia (2004) 1.51
In vitro fertilization is associated with an increase in major birth defects. Fertil Steril (2005) 1.51
Maternal smoking and congenital heart defects. Pediatrics (2008) 1.49
Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy. Sleep (2002) 1.45
The National Niemann-Pick C1 disease database: report of clinical features and health problems. Am J Med Genet A (2007) 1.45
Maternal hypertension, medication use, and hypospadias in the National Birth Defects Prevention Study. Obstet Gynecol (2014) 1.45
Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management. J Child Neurol (2010) 1.44
Exercise-induced left ventricular systolic dysfunction in women heterozygous for dystrophinopathy. J Am Soc Echocardiogr (2010) 1.43
Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial. JAMA (2012) 1.40
Maternal butalbital use and selected defects in the national birth defects prevention study. Headache (2013) 1.39
The extensor plantar response in neonates is not the same as the Babinski sign. Pediatr Neurol (2005) 1.38
Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project. Genet Med (2008) 1.36
The National Down Syndrome Project: design and implementation. Public Health Rep (2007) 1.35
Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension (2009) 1.35
Mortality in Friedreich ataxia. J Neurol Sci (2011) 1.33
Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord (2010) 1.29
Antisense reduction of tau in adult mice protects against seizures. J Neurosci (2013) 1.29
ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc Natl Acad Sci U S A (2010) 1.26
Copy number gain at Xp22.31 includes complex duplication rearrangements and recurrent triplications. Hum Mol Genet (2011) 1.25
The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology. Birth Defects Res A Clin Mol Teratol (2006) 1.24
Clinical and genetic characterization of manifesting carriers of DMD mutations. Neuromuscul Disord (2010) 1.24
PVRL1 variants contribute to non-syndromic cleft lip and palate in multiple populations. Am J Med Genet A (2006) 1.24
Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. Blood (2007) 1.23
Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy. Muscle Nerve (2007) 1.23
Changes in autism spectrum disorder prevalence in 4 areas of the United States. Disabil Health J (2010) 1.23
Integration of DNA sample collection into a multi-site birth defects case-control study. Teratology (2002) 1.22
Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects. Hum Genet (2008) 1.22
Splicing biomarkers of disease severity in myotonic dystrophy. Ann Neurol (2013) 1.22
Corticosteroids in Duchenne muscular dystrophy: major variations in practice. Muscle Nerve (2013) 1.20
Maternal low-level lead exposure and fetal growth. Environ Health Perspect (2010) 1.20
Bayesian methods for correcting misclassification: an example from birth defects epidemiology. Epidemiology (2009) 1.19
Repeated episodes of ozone inhalation amplifies the effects of allergen sensitization and inhalation on airway immune and structural development in Rhesus monkeys. Toxicol Appl Pharmacol (2003) 1.18
Maternal occupational exposure to polycyclic aromatic hydrocarbons: effects on gastroschisis among offspring in the National Birth Defects Prevention Study. Environ Health Perspect (2012) 1.16
Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes. Ann Neurol (2014) 1.15
Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severity. Ann Neurol (2008) 1.14
Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene. Hum Mutat (2011) 1.13
Mode of delivery and neonatal survival of infants with isolated gastroschisis. Obstet Gynecol (2004) 1.13
Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): case definition in surveillance for childhood-onset Duchenne/Becker muscular dystrophy. J Child Neurol (2010) 1.12
Frequency and nature of cerebellar injury in the extremely premature survivor with cerebral palsy. J Child Neurol (2005) 1.12
The National Niemann-Pick Type C1 Disease Database: correlation of lipid profiles, mutations, and biochemical phenotypes. J Lipid Res (2009) 1.12